Video Experimental Relacionado

Updated: May 5, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Análisis colaborativo de la variabilidad del promotor del gen alfa-sinucleína y la enfermedad de Parkinson

Demetrius M Maraganore¹, Mariza de Andrade, Alexis Elbaz

¹Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA. dmaraganore@mayo.edu

|August 10, 2006

Resumen

El riesgo de enfermedad de Parkinson está relacionado con variaciones en el gen SNCA.

Área de la Ciencia:

Genética La genética.
La neurociencia es la neurociencia.
Epidemiología La epidemiología.

Sus antecedentes:

Los estudios genéticos previos de la enfermedad de Parkinson (EP) estaban limitados por tamaños de muestra pequeños y posibles sesgos.
El gen alfa-sinucleína (SNCA) es un sospechoso clave, pero faltaba la validación a gran escala.

Objetivo del estudio:

Para investigar la asociación entre la variabilidad de la longitud del alelo REP1 promotor del gen SNCA y la susceptibilidad a la enfermedad de Parkinson.
Examinar si los haplotipos de promotores SNCA influyen en el riesgo de enfermedad de Parkinson.
Para determinar si la variabilidad de REP1 afecta la edad de inicio de la enfermedad de Parkinson.

Principales métodos:

Un análisis colaborativo de los datos de pacientes individuales de 11 sitios globales.
Genotipización de SNCA REP1 y marcadores flanqueantes en 2692 casos de enfermedad de Parkinson y 2652 controles.
Los análisis estadísticos incluyeron el equilibrio de Hardy-Weinberg, las pruebas de heterogeneidad, los estudios de asociación y los análisis de supervivencia.

Principales resultados:

Se observaron diferencias significativas en las frecuencias del alelo SNCA REP1 entre los casos de enfermedad de Parkinson y los controles (P<.001).
El alelo de 263 pares de bases de SNCA REP1 se asoció con un mayor riesgo de enfermedad de Parkinson (OR, 1.43; P<.001).
Los haplotipos de multilocus, incluido el REP1, se asociaron con la enfermedad de Parkinson, pero la variabilidad del REP1 no afectó la edad al inicio (P = .55).

Conclusiones:

Este estudio a gran escala confirma que la variabilidad de la longitud del alelo SNCA REP1 está asociada con un mayor riesgo de enfermedad de Parkinson.
Los hallazgos destacan la importancia de SNCA REP1 en la patogénesis de la enfermedad de Parkinson.

Más Videos Relacionados

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Videos de Conceptos Relacionados

Pleiotropy

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...

Incomplete Dominance

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...